PhRMA Endorses FDA Safety Over Sequestration Act

WASHINGTON, D.C. (July 22, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) Vice President of Scientific and Regulatory Affairs Sascha Haverfield, PhD, issued the following statement today on ongoing efforts in Congress to resolve the sequestration of prescription drug user fees:

“PhRMA remains deeply concerned about the impact of sequestration on the Food and Drug Administration’s (FDA) ability to fulfill its critical public health mission by fostering timely patient access to safe and effective new medicines and advancing regulatory science.

Importance of Detecting Alzheimer's Disease

07.18.13 | By

Today Show contributor Linda Carroll wrote a great article about the importance of detecting Alzheimer's disease earlier in life.

Protecting Intellectual Property

07.16.13 | By

This week in Malaysia, the United States continues Trans-Pacific Partnership (TPP) negotiations with many of its most important Asia-Pacific trading partners. As we’ve discussed extensively on the Catalyst, through TPP the U.S. aims to expand trade and exports, create new jobs, and help secure its competitive standing in the global marketplace.

Research at May Clinic

07.16.13 | By

I’m not talking about a broken heart from love, but rather from heart disease.

Individualized care, new innovations key to stemming the tide of chronic disease

07.15.13 | By

A chronic disease is detrimental to more than just the person who has it – its impact ripples through the health care system and economy as a whole. According to research by the Robert Wood Johnson Foundation, 80 cents of every dollar spent on health care in the United States goes to treat chronic disease. Its significance cannot be overstated.

Week in Review: Supporting the Fight Against Chronic Disease

07.12.13 | By

The increasing burden of chronic diseases, as well as potential solutions to the problem, were a major focus for us this week.

Amicus Brief in FTC v. Actavis

Exploring Health Policy

07.09.13 | By

From cancer and diabetes to heart disease and hypertension, prevalence of chronic disease in America has reached epidemic proportions. In the U.S., 75 percent of our health care dollars go toward its treatment.

One Year Later

07.09.13 | By

It was one year ago today that the Food and Drug Administration Safety and Innovation Act (FDASIA) was signed into law, reauthorizing the Prescription Drug User Fee Act (PDUFA), permanently reauthorizing the Best

‘Conversations’ Round-Up

07.09.13 | By

Every day, our industry works to develop new medicines that extend and improve the quality of life for patients. As the Baby Boom generation enters retirement age, one critical health care issue that we must address is how to keep our nation’s seniors healthy. It’s a topic that I come across regularly in my role at PhRMA.


Subscribe to RSS - Opinion